Warnings: Not recommended for pregnant or breastfeeding women, or for children
To manage outcomes and costs, one in three (34%) firms now require employees to participate in lifestyle or clinical support programs before allowing clinical approval of GLP-1 agonists for weight loss
2 Wegovy is available on the NHS for adults with: A BMI of 35 or higher (32.5 or higher for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) At least one weight-related condition (type 2 diabetes, hypertension, cardiovascular disease, obstructive sleep apnoea, or dyslipidaemia) Referral to and engagement with a specialist weight management service (Tier 3) NICE caps NHS treatment with Wegovy at two years
Bain MA, Milne RW, Evans AM (2006) Disposition and metabolite kinetics of oral L-carnitine in humans